Skip to content

Dealing with drug-resistant TB

April 9, 2013

African Press International (API)

LONDON,  – Twenty years ago, tuberculosis (TB) was one of the least glamorous branches of medicine. The cause had long been known, as had the cure, so all that was left was the unromantic slog of reducing the poverty, hunger and overcrowding that fostered the disease, and working out better ways to get patients to comply with the lengthy course of treatment needed to cure it. 

But in 1993 the sudden upsurge in TB cases associated with HIV and AIDS, and the growth of multidrug-resistant (MDR) strains of the bacterium, led the World Health Organization (WHO) to declare the disease a global emergency, which unlocked research funding. Now we are beginning to see the results.

Authors contributing to a special series of articles published by the London-based medical journal, The Lancet, note that “these investments have led to the most promising pool of new tuberculosis drug and…

View original post 923 more words


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: